Avantor (AVG) Stock Price & Analysis
AVG Stock Chart & Stats
- Day’s Range
- EUR 14.38 - EUR 14.92
- 52-Week Range
- EUR 6.30 - EUR 15.62
- Previous Close
- EUR 14.98
- Volume
- 0
- Average Volume (3M)
- 43
- Market Cap
- EUR 9.71B
- Enterprise Value
- EUR 13.47B
- Total Cash (Recent Filing)
- EUR 464.30M
- Total Debt (Recent Filing)
- EUR 3.68B
- Price to Earnings (P/E)
- 32.0
- Beta
- 0.20
- Next Earnings
- Feb 04, 2027 (Est.)
- EPS Estimate
- 0.2
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Return To Organic Growth
The return to organic growth across the company indicates improving demand and execution after a period of weaker performance. Raised full-year guidance and positive fourth-quarter assumptions suggest the recovery may extend beyond one quarter and support more durable revenue momentum.
Recurring Mission-critical Demand
Recurring purchases and qualification requirements can make Avantor an embedded supplier rather than a discretionary vendor. Customer integration through procurement, inventory management, and regulated production workflows supports repeat revenue and can create switching friction over multiple periods.
Cash Generation And Deleveraging
Strong free cash flow gives Avantor internal funding capacity while debt reduction improves balance-sheet resilience. Continued deleveraging can lower financial pressure, preserve flexibility for growth investments, and strengthen the company’s ability to manage demand or margin volatility.
Bears Say
Margin Pressure
If pricing continues to lag cost inflation, revenue growth may not translate efficiently into earnings or cash flow. Mix effects from faster growth in lower-margin VWR and ongoing investment needs could keep margins below prior peaks and limit profitability recovery.
Choppy Long-term Revenue Trend
Recent improvement follows a period in which the business did not consistently expand its revenue base or preserve historical margins. This uneven record raises uncertainty about the durability of the recovery and whether current growth can restore prior earnings power.
Weak European Market
A prolonged European slowdown can restrain demand across Avantor’s research, education, industrial, and biopharma customer base. Management’s guidance assumes a static European environment, so limited regional improvement could keep growth and operating leverage below potential.
AVG FAQ
What was Avantor’s price range in the past 12 months?
What is Avantor’s market cap?
When is Avantor’s upcoming earnings report date?
How were Avantor’s earnings last quarter?
Is Avantor overvalued?
Does Avantor pay dividends?
What is Avantor’s EPS estimate?
How many shares outstanding does Avantor have?
What happened to Avantor’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Avantor?
What is the TipRanks Smart Score and how is it calculated?
Avantor Stock Smart Score
Company Description
Avantor
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Emmanuel Ligner
- Employees
- 13,500
- Website
- www.avantorsciences.com
- Address
- Radnor Corporate Center, Radnor, PA, 19087, US
Avantor (AVG) Earnings & Revenues
AVG Company Deck
AVG Earnings Call
Earnings Call SentimentPositive
The call was strongly constructive. Avantor reported a return to organic growth, outperformance in both revenue and adjusted EPS, positive performance in VWR and BMP, robust free cash flow, lower leverage, improved order trends, and raised full-year guidance. The main challenges were mix and inflationary margin pressure, foreign-exchange headwinds, BMP comparison effects, pricing that remains below inflation, and a lagging European market. Highlights significantly outweighed the lowlights.
View all DE:AVG earnings summariesAVG Net sales Breakdown
- 58.44% Americas
- 34.74% Europe
- 6.82% AMEA
AVG Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 9 | 6 | 7 |
| Technical Analysis | 3 | 6 | 1 |
| Moving Averages | 6 | 0 | 6 |